drugset / Trial / NCT05786573
A Study of Obexelimab in Patients With Warm Autoimmune Hemolytic Anemia (SApHiAre)
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study aims to examine the efficacy and safety of obexelimab in participants with Warm Autoimmune Hemolytic Anemia (wAIHA).
Timeline
- Start
- 2023-09-25
- Primary completion
- 2026-06-30
- Completion
- 2026-08-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Obexelimab | Monoclonal antibody | — | Subcutaneous |